A concern with the existing forms of noninvasive brain stimulation such as conventional magnetic and direct current stimulation is the risk of treatment emergent affective switch (mania/ hypomania) or TEAS(1). However, to our knowledge, there are no reported cases in patients receiving TBS. We describe here, a series of three cases of depression who developed TEAS during or soon after TBS sessions. Each of these received bilateral TBS protocol at 80% of resting motor threshold, using MagVenture-MagPro-X100 device with a figure-of-8 coil, administered as 1800 intermittent pulses with a 2s stimulation-interval and 8s inter-train interval (iTBS) over left dorsolateral prefrontal cortex (DLPFC) followed by
using International 10/20 EEG system.
Case 1
Master S, a 17-year-old adolescent male presented with 3-months history of a moderate depressive episode following death of his mother. His past and family psychiatric history were unremarkable. He had received a failed two-month trial of Vortioxetine 20mg and was off medications at the time of presentation. He was admitted and started on Escitalopram 10mg along with individual therapy. Ten sessions of TBS were given as adjunctive treatment.
His Children's Depression Rating Scale-Revised(CDRS-R) scores dropped from 49 (Day 0 of TBS) to 28. However, 6 days after the last TBS session(27 th day after starting Escitalopram) he developed new-onset symptoms characterized by decreased need for sleep, increased activity levels: practicing music for 10 hours a day, overfamiliarity, overtalkativeness and risk-taking behavior such as asking strangers to wrestle with him. Escitalopram was stopped immediately and replaced with Aripiprazole 10mg, on which he achieved remission in 5 days. At three-months follow-up, he remained euthymic on Aripiprazole.
Case 2
Miss L, a 17-year-old adolescent female, presented with two-months history of severe depression (CDRS-R score of 60). There was family history of bipolar affective disorder in her father and history of suicide in two second-degree relatives. She was started on Sertraline, titrated up to 100mg and TBS was added as an adjunct. Her onset insomnia worsened after first session and there was rapid improvement in depressive symptoms and suicidality. By third session(9 th day after starting Sertraline), she developed frank manic symptoms characterized by elated mood, reduced need for sleep, overtalkativeness and loss of social inhibitions -she would dance in the ward and was very intrusive and overfamiliar with other patients. Her Young Mania Rating Scale(YMRS) score was 25. Even after stopping Sertraline and TBS, her symptoms kept worsening. Hence, she was started on Lithium 900mg in combination with Quetiapine 200mg with which she achieved remission in two weeks. At her last follow up after about six-months, she continues to remain in remission on the same.
Case 3
Miss. J, a 21-year-old female, was a known case of Bipolar affective disorder(type I) for the past 5 years. She presented with a severe depressive episode of three weeks duration without psychotic symptoms(Hamilton Depression Rating Scale score of 25). Family history was unremarkable. She had history of TEAS with Sertraline in the past year. She was admitted in view of suicidality and was started on Quetiapine titrated up to 600mg over 3 weeks along with individual therapy. However, in view of partial improvement, TBS was added for augmentation. By five sessions, she reported slight improvement in mood and stopped expressing suicidal thoughts. By ten sessions, her mood and psychomotor activity had improved significantly and she did not report any negative cognitions(HDRS score of 4). On the eleventh day, she became elated. She was seen laughing and singing in the ward and had increased self-esteem. She started demanding money from her mother to buy clothes and makeup accessories and also requested her doctors to let her buy a puppy for herself to keep in the hospital, which her mother reported, was unlike her usual self. Hence, her TBS sessions were discontinued and quetiapine 600mg monotherapy was continued. Her hypomanic symptoms lasted for five days before she became euthymic and remained so after 3 months of discharge.
Discussion
To our knowledge, this is the first description of TEAS in patients receiving TBS for depression. Recent data of TEAS with conventional rTMS suggests that these might be associated with higher stimulation strengths and longer stimulation periods (1) . In our case, patients had received sub-motor-threshold doses and developed TEAS with fewer sessionsas early as third session in one instance. Case-1 and 2 were part of an on-going clinical trial evaluating the safety and efficacy of TBS in adolescents with depression. The early age of onset in these cases and family history of bipolar disorder in one of these might be pointers towards underlying bipolarity. In the presence of these, there is a need for careful monitoring for rapid improvement of depressive symptoms and new-onset sleep disturbances which could be early signs of impending TEAS. Both these patients were also on antidepressants during TBS sessions, which could have acted synergistically in causing TEAS, as noted previously in some case reports (2) (3) (4) . Case-3 was on quetiapine alone and may have developed TEAS due to the underlying biological vulnerability, suggested by the past history of antidepressant induced switch. In our center, of the 26 adolescents who received TBS for depression, 2 (7.7%) developed TEAS as compared to 1 of 84 (1.2%) adults. Thus, the risk of TBS induced TEAS is 6.4 times greater in adolescents as compared to adults. It is also noteworthy that of all patients, 9 adults and 2 adolescents had a diagnosis of bipolar depression and completed sessions without an incidence of affective switch. Each of these was on at least one mood stabilizer while receiving TBS. Recent reviews recommend starting such patients on mood stabilizers before commencing neuromodulatory therapies (5, 6) . That being said, it is important to recollect that attributing causality in cases of TEAS is difficult owing to the unpredictable natural course of the underlying illness itself (7) .
Well-designed sham-controlled RCTs on TBS in depression will help in establishing causation. Further research to elucidate neurobiological mechanisms underlying TEAS is also warranted.
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